Monday, April 18, 2022

RBLBANK

RBLBANK(RBL Bank Limited)

05.01.2023 - MS on RBLBANK Maintain Underweight CMP 177.75 Target 130
03.12.2022 - MS on RBLBANK Maintain Underweight CMP 151.4 Target130

25.10.2022 - MS on RBLBANK Maintain Underweight CMP 136.9 Target 115
22.06.2022 - CS on RBLBANK Maintain Underperform CMP 91 Target 86
22.06.2022 - BOFA on RBLBANK Maintain Underperform CMP 91 Target 110
13.06.2022 - CLSA on RBLBANK Maintain Outperform CMP 87.6 Target 130
13.05.2022 - JpMorgan on RBLBANK Maintain Neutral CMP 102 Target 110 (PREV TGT 170)
07.04.2022 - MS on RBLBANK Maintain Underweight CMP 139.80 Target 140
28.01.2022 - CS on RBLBANK Maintain Underperform CMP 153.40 Target 135 (PREVTGT 180)
28.01.2022 - CLSA on RBLBANK Maintain Buy CMP 153.40 Target 200
27.12.2021 - CLSA on RBLBANK Maintain outperform - Target 200
27.12.2021 - Investec on RBLBANK Maintain Buy CMP 173 - Target 295
27.12.2021 - ICICI SEC on RBLBANK Downgrade Sell CMP 173 - Target 130
27.12.2021 - CLSA on RBLBANK Maintain outperform CMP 173 - Target 200

INVESTEC ON RBL BANK : 27.12.2021

• Rating for RBL Bank is under-review
* RBI inducts board member & forces CEO change
• RBL has strong capitalization vs other previous instances of RBI intervention
• New management reiterates guidance & continuity of BAF partnership
* Recommendation changed to under review (from BUY)

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830